Electromed (ELMD) vs InfuSystems (INFU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
InfuSystems (INFU) has outperformed Electromed (ELMD) over the past year, gaining 36.6% versus a gain of 10.7%. Over five years, ELMD leads with a +153.0% price change compared with +4.2% for INFU. InfuSystems is the larger company by market cap ($270.1 million vs $229.5 million), about 1.2 times the size.
On valuation, InfuSystems trades at a lower forward P/E (26.1x vs 45.4x for Electromed).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | INFU |
|---|---|---|
| Share price | $27.69 | $13.56 |
| Market cap | $229.47M | $270.08M |
| 1-day change | -0.40% | +1.12% |
| YTD return | -4.53% | +49.50% |
| 1-year return | +10.67% | +36.56% |
| 5-year return | +152.96% | +4.20% |
| P/E ratio (TTM) | 21.30 | 33.90 |
| Forward P/E | 45.39 | 26.08 |
| EPS (TTM) | $1.30 | $0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $13.85 |
| 52-week low | $23.01 | $7.29 |
| Distance from 52-week high | -41.58% | -2.09% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +75.15% | +24.12% |
| Average volume | 104.86K | 140.07K |
| Shares outstanding | 8.29M | 19.92M |
| Employees | 195 | 461 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INFU has outperformed ELMD by 25.9 percentage points over the past year.
- InfuSystems trades at a higher earnings multiple (33.9x vs 21.3x trailing P/E).
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About InfuSystems
INFU stock →InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.
Health Care · Medical/Dental Instruments · 461 employees
ELMD vs INFU FAQ
Which is bigger, Electromed or InfuSystems?
InfuSystems (INFU) is larger, with a market capitalization of $270.08M compared with $229.47M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or INFU?
INFU returned +36.56% over the past 12 months, compared with +10.67% for ELMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELMD or INFU?
ELMD has the lower trailing P/E at 21.3, versus 33.9 for INFU. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Electromed and InfuSystems in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Electromed and Medical/Dental Instruments for InfuSystems.